<SEC-DOCUMENT>0001193125-22-237187-index.html : 20220902
<SEC-HEADER>0001193125-22-237187.hdr.sgml : 20220902
<ACCEPTANCE-DATETIME>20220902083029
ACCESSION NUMBER:		0001193125-22-237187
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20221013
FILED AS OF DATE:		20220902
DATE AS OF CHANGE:		20220902

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Candel Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001841387
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				522214851
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40629
		FILM NUMBER:		221223276

	BUSINESS ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 450
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494
		BUSINESS PHONE:		617-916-5445

	MAIL ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 450
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Candel Therapeutics, Inic.
		DATE OF NAME CHANGE:	20210120
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d392786ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: d392786ddef14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g392786sp1aaa.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: g392786sp1aaa.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g392786sp20a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g392786sp20a.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g392786sp20b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g392786sp20b.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g392786sp2aaa.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g392786sp2aaa.jpg

</DOCUMENT>
</SEC-DOCUMENT>